Why the study?
The study aimed to create a novel prediction model for cardiovascular death that incorporates lifestyle factors alongside known risk factors.
Does a prediction model incorporating lifestyle factors in addition to known risk factors improve predictive ability for cardiovascular death in adults aged 40-74 years?
Does a prediction model incorporating lifestyle factors in addition to known risk factors improve predictive ability for cardiovascular death in adults aged 40-74 years?
Adding lifestyle factors such as weight gain, exercise habit, gait speed, and alcohol consumption to known risk factors improves the prediction of cardiovascular death.
Supports lifestyle-inclusive CV death prediction in Japanese adults; leaves open external validation before clinical use.
This longitudinal cohort study aimed to create a novel prediction model for cardiovascular death with lifestyle factors. Subjects aged 40-74 years in the Japanese nationwide Specific Health Checkup Database in 2008 were included. Subjects were randomly assigned to the derivation and validation cohorts by a 2:1 ratio. Points for the prediction model were determined using regression coefficients that were derived from the Cox proportional hazards model in the derivation cohort. Models 1 and 2 were developed using known risk factors and known factors with lifestyle factors, respectively. The models were validated by comparing Kaplan-Meier curves between the derivation and validation cohorts, and by calibration plots in the validation cohort. Among 295,297 subjects, data for 120,823 were available. There were 310 cardiovascular deaths during a mean follow-up of 3.6 years. Model 1 included known risk factors. In model 2, weight gain, exercise habit, gait speed, and drinking alcohol were additionally included as protective factors. Kaplan-Meier curves matched better between the derivation and validation cohorts in model 2, and model 2 was better calibrated. In conclusion, our prediction model with lifestyle factors improved the predictive ability for cardiovascular death.
No takes yet. Share an insight, caveat, or question.
Nishimoto et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: